CONCORDBIO

Concord Biotech Limited

Pharmaceuticals

An R&D-driven biopharma company engaged in manufacturing fermentation-based active pharmaceutical ingredients for immunosuppressants and oncology applications. Established in 1984, the company specializes in complex fermentation technology and serves domestic and international pharmaceutical markets with differentiated API solutions. Its focus on bioprocess innovation and vertical integration in fermentation-based manufacturing distinguishes it within the competitive global pharmaceutical ingredients landscape.

Investors holding Concord Biotech Limited

Government Pension Fund Global (Norway)

Foreign Investor

2.95%

Tata AIA Life Insurance

Institution

2.48%

Max Life Insurance

Institution

1.34%

Latest move